ritlecitinib 50 MG Oral Capsule [Litfulo]
RxNorm concept 2641607, branded drug (sbd). Prescribable name: Litfulo 50 MG Oral Capsule.
- RxCUI
- 2641607
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2641607 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Litfulo 50 MG (equivalent to ritlecitinib tosylate 80.13 MG) Oral Capsule
Related concepts
- ritlecitinib 50 MG (SCDC, consists of)
- ritlecitinib 50 MG [Litfulo] (SBDC, consists of)
- Oral Capsule (DF, has dose form)
- Litfulo (BN, has ingredient)
- ritlecitinib 50 MG Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2641607 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2641607 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2641607. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.